Research Summary:
We could not adequately summarise this research paper as it is behind a paywall. We have therefore summarised the abstract and provided a link to it.
The researchers did a systematic review of research articles up to January 29th 2024.
The objective was to assess the relationship between different treatments given to people that had an acute infection with SARS-CoV-2 (commonly known as an acute COVID infection) and whether this reduced their risk of developing Long COVID.
The treatments compared were antivirals, corticosteroids, monoclonal antibodies.
Their conclusions were that ANTIVIRALS reduced the risk of developing Long COVID and should be recommended to treat an acute COVID infection.
They also found that ANTIVIRALS provided a stronger protection in the elderly, males unvaccinated and non-diabetic populations.
Credible Source:
SUMMARY of abstract of: Sun G, Lin K, Ai J, Zhang W. “The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID: a Systematic Review and meta-analysis”. Clinical Microbiology and Infection. 2024 Jul 14.
